# Senate Commission Says China Is Seizing Drug Supply Chain, Pushes For Congressional Action

- URL: https://talkfuse.com/story/senate-commission-says-china-is-seizing-drug-supply-chain-pushes-for-congressional-action/
- Published: 2026-11-19T21:33:23+00:00
- Updated: 2026-11-19T22:54:05+00:00
- Original publisher: The Daily Caller (publisher lean: Right)
- Original article: https://dailycaller.com/2026/11/19/nsceb-senate-commission-china-ccp-todd-young
- Topics: Asia, Government, Health, Medicine, Politics, World

## Key points

- Senate commission warns China is gaining influence over drug supply chains.
- Its analysis reviewed 57 deals involving Western and Chinese biotech firms.
- Senators Young and Padilla’s proposed bill would authorise $50 million.

## Summary

A US Senate commission says China is gaining influence over global drug and biopharmaceutical supply chains, and warns that deals between Western pharmaceutical companies and Chinese biotech firms could weaken US research and development. It is urging Congress to advance legislation intended to strengthen American biotechnology and speed up the path from research to market.

The commission analysed 57 deals made from early 2023 to October, involving investment and licensing agreements; AstraZeneca, Bristol Myers Squibb and Pfizer were among the companies cited. The proposed bipartisan National Biotechnology Safety Act, introduced by Senators Todd Young and Alex Padilla in September 2025, was referred to the Senate HELP Committee, with no further action reported. The commission says it would authorise $50 million from 2026 to 2030 for research and regulatory changes to help US biotech products reach the market sooner.

---
Summarised by TalkFuse (https://talkfuse.com/). Quote the original publisher for the reporting and link this page for the summary and discussion.
